@RuthAnnMathew Profile picture

Ruth Ann Mathew Kalathil

@RuthAnnMathew

PGY-3 IM @Creighton, aspiring cardiologist.

Pinned

ESC London. Excited to present our paper on outcomes of atrial fibrillation in heart failure. #ESCCongress

Tweet Image 1
Tweet Image 2

Ruth Ann Mathew Kalathil Reposted

It was truly one of the greatest honors of my life to serve as the inaugural @Creighton University Alumni Visiting Lecturer. Loved my 1.5 days in Omaha, connecting with old friends and teachers, and discussing #MDT in acute CV care. Many thanks to the DOM for the opportunity.

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Fantastic panel discussion on INOCA today .Engaging insights from all the experts, including @purviparwani made for a thought-provoking session. It was a pleasure chatting with you. #Cardiology #ESCCongress2024


Ruth Ann Mathew Kalathil Reposted

How many times have we seen this flow chart on the duration of DAPT change over the years? Let’s summarize the situation regarding class I recommendations (“must be done”) as reported in the new 2024 guidelines on chronic coronary syndromes: - High bleeding risk patient: DAPT…

Tweet Image 1

Ruth Ann Mathew Kalathil Reposted

#ESCcongress #AF guidelines What’s new?➡️ 🆕 importance of optimal care according to the new AF-CARE pathway, C] Comorbidity and risk factor management; A] Avoid stroke and thromboembolism; R] Reduce symptoms by rate and rhythm control; E] Evaluation and dynamic…

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

#ESCCongress ➡️what’s new with #BP guidelines?? #MedTwitter #CardioTwitter #CardioX ❤️ new category of 'Elevated BP' with BP 120-139/70-89 mmHg. ❤️ new systolic BP treatment target range of 120-129 mmHg for most patients receiving BP-lowering meds ❤️ pragmatic…

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4


Ruth Ann Mathew Kalathil Reposted

The Sc is gone... ...#CHA2DS2-VA New ESC #Afib guidelines presented at #ESCcongress

Tweet Image 1

Ruth Ann Mathew Kalathil Reposted

ABYSS trial showed interrupting B-blocker in MI with preserved LVEF > 40% is not different from continuing B-blockers with regards to composite of death, MI, stroke, or CV hospitalization. Interrupting B-blockers resulted in higher hospitalization rate #ESCCongress #cardiology

Tweet Image 1

Finally submitted my cardiology fellowship application! Grateful beyond words for all the mentorship. Here’s to new challenges and opportunities. Godspeed! #Cardiology #fellowship

Tweet Image 1

Ruth Ann Mathew Kalathil Reposted

Congrats to @RuthAnnMathew and @Dr_Akshay_MB for leading this important analysis! @BrownMedicine @BrownCardiology

Is there a role of PCI in ischemic cardiomyopathy? Check out our article on this hot topic🔥@mcpquality 🎯NO difference in all-cause mortality☠️ with PCI revascularization compared to optimal medical therapy @RuthAnnMathew @AGoldsweig @SarasVallabhMD @kdahal11 #cardiotwitter

Tweet Image 1
Tweet Image 2


Ruth Ann Mathew Kalathil Reposted

Is there a role of PCI in ischemic cardiomyopathy? Check out our article on this hot topic🔥@mcpquality 🎯NO difference in all-cause mortality☠️ with PCI revascularization compared to optimal medical therapy @RuthAnnMathew @AGoldsweig @SarasVallabhMD @kdahal11 #cardiotwitter

Tweet Image 1
Tweet Image 2

Excited to share our new paper on PCI Vs medical management in stable CAD with severe LV systolic dysfunction. Grateful to the brilliant minds behind our research. Thank you! @Dr_Akshay_MB @SarasVallabhMD @AGoldsweig @kdahal11 doi.org/10.1016/j.mayo….


Our abstract has been accepted for #ESCCongress - can't wait to present it! escol.escardio.org/MyESC/modules/…


Ruth Ann Mathew Kalathil Reposted

Very important discussion @SCAI re: cross section of IC/HF/CC. The modern IC is no longer a just coronary operator & needs to be adept with full spectrum of acute🫀care. Spectacular and inspiring discussion @SrihariNaiduMD @agtruesdell @SarasVallabhMD 👏🏽 #SCAI2024

Tweet Image 1

Honored to present our Featured research at SCAI. Outcomes of Mechanical Thrombectomy vs contemporary strategies in intermediate and high risk PE. doi.org/10.1016/j.jsca… #SCAI2024 #Jscai

Tweet Image 1

Ruth Ann Mathew Kalathil Reposted

📣Pulmonary Embolism Featured Abstract at #SCAI2024: 💡Outcomes of #MechanicalThrombectomy vs Contemporary Treatments Modalities for Intermediate & High-Risk #PE: A Systematic Review & Metanalysis ➡️doi.org/10.1016/j.jsca… @Dr_Akshay_MB @PusapatiSuma_Dr @HasaanAhmedMD

Tweet Image 1
Tweet Image 2

Microplastics and Nanoplastics in Atheromas and Cardiovascular Events | New England Journal of Medicine nejm.org/doi/full/10.10… While it is unusual to think of nano plastics in athermomas, preclinical studies have shown adverse clinical outcomes associated with it.


Chasing our dreams and shaping the further of cardiac health with these awesome ladies! 🙌 . Shoutout to the phenomenal women leading the charge in cardiology, @KTamirisaMD , chatting with you was truly inspiring!, @DrMarthaGulati, @gina_lundberg

Tweet Image 1

Big shoutout to my fellow colleagues who contributed to our abstracts in #ACC24.

Tweet Image 1

United States Trends
Loading...

Something went wrong.


Something went wrong.